ResMed
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ResMed's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11% to $4,685,297,000. The net income raised on $1,020,951,000 and profit margin reached 22%. Total operating expenses were $1,335,410,000.
Profit Margin
| 2015 | 1.67B | 352.88M | 21.02% |
|---|---|---|---|
| 2016 | 1.83B | 352.40M | 19.17% |
| 2017 | 2.06B | 342.28M | 16.56% |
| 2018 | 2.34B | 315.58M | 13.49% |
| 2019 | 2.60B | 404.59M | 15.52% |
| 2020 | 2.95B | 621.67M | 21.02% |
| 2021 | 3.19B | 474.50M | 14.84% |
| 2022 | 3.57B | 779.43M | 21.78% |
| 2023 | 4.22B | 897.55M | 21.25% |
| 2024 | 4.68B | 1.02B | 21.79% |
RMD Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 4.68B | 4.22B | 3.57B | 3.19B | 2.95B | 2.60B | 2.34B | 2.06B | 1.83B | 1.67B |
Cost of revenue | 2.02B | 1.86B | 1.55B | 1.35B | 1.23B | 1.06B | 978.03M | 864.99M | 772.21M | 667.51M |
Gross profit | 2.65B | 2.35B | 2.02B | 1.83B | 1.71B | 1.53B | 1.36B | 1.20B | 1.06B | 1.01B |
Operating exp. | ||||||||||
Research and development | 307.52M | 287.64M | 253.57M | 225.28M | 201.94M | 180.65M | 155.14M | 144.46M | 118.65M | 114.86M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.46M | -6M |
Total operating expenses | 1.33B | 1.20B | 1.02B | 926.74M | 908.72M | 900.59M | 801.90M | 745.01M | 625.16M | 596.16M |
Operating income | 1.31B | 1.13B | 1.00B | 903.67M | 809.65M | 579.26M | 541.83M | 425.79M | 428.95M | 409.23M |
Other income (expenses), net | -55.09M | -30.20M | -39.80M | -20.01M | -76.57M | -60.41M | -26.97M | -7.05M | -7.41M | 26.68M |
Income before tax | 1.26B | 1.10B | 960.48M | 883.66M | 733.08M | 518.84M | 521.31M | 418.74M | 439.56M | 435.91M |
Income tax expense | 243.84M | 204.10M | 181.04M | 409.15M | 111.41M | 114.25M | 205.72M | 76.45M | 87.15M | 83.03M |
Net income | 1.02B | 897.55M | 779.43M | 474.50M | 621.67M | 404.59M | 315.58M | 342.28M | 352.40M | 352.88M |
Earnings per share | ||||||||||
Basic EPS | 6.94 | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 | 2.21 | 2.42 | 2.51 | 2.51 |
Diluted EPS | 6.92 | 6.09 | 5.3 | 3.24 | 4.27 | 2.8 | 2.19 | 2.4 | 2.49 | 2.47 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |